nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisone—Crohn's disease	0.613	1	CiPCiCtD
Fluticasone Propionate—NR3C1—Prednisone—Crohn's disease	0.0367	0.63	CbGbCtD
Fluticasone Propionate—Prednicarbate—Prednisone—Crohn's disease	0.0189	0.0676	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisone—Crohn's disease	0.0184	0.0657	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisone—Crohn's disease	0.0179	0.0639	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisone—Crohn's disease	0.0174	0.0622	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisone—Crohn's disease	0.0169	0.0605	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisone—Crohn's disease	0.0169	0.0605	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisone—Crohn's disease	0.0169	0.0605	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisone—Crohn's disease	0.0165	0.059	CrCrCtD
Fluticasone Propionate—CYP3A5—Sulfasalazine—Crohn's disease	0.0164	0.282	CbGbCtD
Fluticasone Propionate—Desoximetasone—Prednisone—Crohn's disease	0.0161	0.0576	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisone—Crohn's disease	0.0157	0.0562	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisone—Crohn's disease	0.0157	0.0562	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisone—Crohn's disease	0.0157	0.0562	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisone—Crohn's disease	0.0157	0.0562	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisone—Crohn's disease	0.0154	0.0549	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisone—Crohn's disease	0.0154	0.0549	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisone—Crohn's disease	0.0154	0.0549	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisone—Crohn's disease	0.0147	0.0526	CrCrCtD
Fluticasone Propionate—CYP3A4—Prednisone—Crohn's disease	0.00512	0.0879	CbGbCtD
Fluticasone Propionate—PLA2G4A—Hydrolysis of LPC—PLA2G4F—Crohn's disease	0.00163	0.12	CbGpPWpGaD
Fluticasone Propionate—Secondary infection—Azathioprine—Crohn's disease	0.00122	0.0348	CcSEcCtD
Fluticasone Propionate—NR3C2—Preimplantation Embryo—SOX11—Crohn's disease	0.00109	0.0803	CbGpPWpGaD
Fluticasone Propionate—Secondary adrenocortical insufficiency—Prednisone—Crohn's disease	0.000993	0.0284	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Mercaptopurine—Crohn's disease	0.000944	0.027	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Acyl chain remodelling of PI—PLA2G4F—Crohn's disease	0.000935	0.0691	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Acyl chain remodelling of PG—PLA2G4F—Crohn's disease	0.000891	0.0658	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Acyl chain remodelling of PS—PLA2G4F—Crohn's disease	0.000891	0.0658	CbGpPWpGaD
Fluticasone Propionate—Cushing's syndrome—Prednisone—Crohn's disease	0.000758	0.0217	CcSEcCtD
Fluticasone Propionate—Growth retardation—Prednisone—Crohn's disease	0.000758	0.0217	CcSEcCtD
Fluticasone Propionate—Telangiectasia—Prednisone—Crohn's disease	0.000731	0.0209	CcSEcCtD
Fluticasone Propionate—Ache—Mesalazine—Crohn's disease	0.000705	0.0202	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Acyl chain remodelling of PE—PLA2G4F—Crohn's disease	0.000699	0.0517	CbGpPWpGaD
Fluticasone Propionate—Acneiform eruption—Prednisone—Crohn's disease	0.000682	0.0195	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Acyl chain remodelling of PC—PLA2G4F—Crohn's disease	0.000654	0.0484	CbGpPWpGaD
Fluticasone Propionate—Candida infection—Mercaptopurine—Crohn's disease	0.000572	0.0164	CcSEcCtD
Fluticasone Propionate—Skin atrophy—Prednisone—Crohn's disease	0.00057	0.0163	CcSEcCtD
Fluticasone Propionate—Skin striae—Prednisone—Crohn's disease	0.000541	0.0155	CcSEcCtD
Fluticasone Propionate—Psoriasis—Mesalazine—Crohn's disease	0.000518	0.0148	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Mesalazine—Crohn's disease	0.000512	0.0147	CcSEcCtD
Fluticasone Propionate—Dermatitis acneiform—Prednisone—Crohn's disease	0.000504	0.0144	CcSEcCtD
Fluticasone Propionate—Hypertrichosis—Prednisone—Crohn's disease	0.000453	0.013	CcSEcCtD
Fluticasone Propionate—Throat sore—Mesalazine—Crohn's disease	0.000451	0.0129	CcSEcCtD
Fluticasone Propionate—Blister—Mesalazine—Crohn's disease	0.000451	0.0129	CcSEcCtD
Fluticasone Propionate—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.000447	0.0128	CcSEcCtD
Fluticasone Propionate—Dermatitis atopic—Mesalazine—Crohn's disease	0.00044	0.0126	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Mesalazine—Crohn's disease	0.000425	0.0122	CcSEcCtD
Fluticasone Propionate—Leukoderma—Prednisone—Crohn's disease	0.000405	0.0116	CcSEcCtD
Fluticasone Propionate—Rhinorrhoea—Mesalazine—Crohn's disease	0.000402	0.0115	CcSEcCtD
Fluticasone Propionate—Intraocular pressure increased—Prednisone—Crohn's disease	0.000391	0.0112	CcSEcCtD
Fluticasone Propionate—Oropharyngeal pain—Mesalazine—Crohn's disease	0.000358	0.0103	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Mesalazine—Crohn's disease	0.000316	0.00905	CcSEcCtD
Fluticasone Propionate—Candida infection—Mesalazine—Crohn's disease	0.000311	0.0089	CcSEcCtD
Fluticasone Propionate—Osteoporosis—Prednisone—Crohn's disease	0.000307	0.0088	CcSEcCtD
Fluticasone Propionate—Fracture—Prednisone—Crohn's disease	0.000296	0.00849	CcSEcCtD
Fluticasone Propionate—Multiple fractures—Prednisone—Crohn's disease	0.000296	0.00849	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Mercaptopurine—Crohn's disease	0.000272	0.00779	CcSEcCtD
Fluticasone Propionate—PGR—Cellular roles of Anthrax toxin—IL18—Crohn's disease	0.000263	0.0195	CbGpPWpGaD
Fluticasone Propionate—Eczema—Mesalazine—Crohn's disease	0.000263	0.00753	CcSEcCtD
Fluticasone Propionate—Malnutrition—Mercaptopurine—Crohn's disease	0.000262	0.00751	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear signaling by ERBB4—RBX1—Crohn's disease	0.000255	0.0188	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.00025	0.0185	CbGpPWpGaD
Fluticasone Propionate—Atrial fibrillation—Mesalazine—Crohn's disease	0.000249	0.00714	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Mesalazine—Crohn's disease	0.000247	0.00708	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisone—Crohn's disease	0.000246	0.5	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisone—Crohn's disease	0.000246	0.5	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.000239	0.0177	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—KSR1—Crohn's disease	0.000238	0.0176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000233	0.0172	CbGpPWpGaD
Fluticasone Propionate—Dermatitis atopic—Prednisone—Crohn's disease	0.000233	0.00666	CcSEcCtD
Fluticasone Propionate—Glaucoma—Prednisone—Crohn's disease	0.000229	0.00655	CcSEcCtD
Fluticasone Propionate—Face oedema—Mesalazine—Crohn's disease	0.000228	0.00653	CcSEcCtD
Fluticasone Propionate—Arthralgia—Mercaptopurine—Crohn's disease	0.000223	0.00639	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000222	0.00635	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Crohn's disease	0.00022	0.0162	CbGpPWpGaD
Fluticasone Propionate—Abdominal discomfort—Azathioprine—Crohn's disease	0.000215	0.00615	CcSEcCtD
Fluticasone Propionate—Oedema—Mercaptopurine—Crohn's disease	0.000214	0.00613	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Mesalazine—Crohn's disease	0.000213	0.00609	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Mesalazine—Crohn's disease	0.000211	0.00605	CcSEcCtD
Fluticasone Propionate—Skin disorder—Mercaptopurine—Crohn's disease	0.000208	0.00595	CcSEcCtD
Fluticasone Propionate—Endocrine disorder—Prednisone—Crohn's disease	0.000208	0.00595	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Mesalazine—Crohn's disease	0.000206	0.00589	CcSEcCtD
Fluticasone Propionate—Asthma—Mesalazine—Crohn's disease	0.000204	0.00585	CcSEcCtD
Fluticasone Propionate—Pneumonia—Azathioprine—Crohn's disease	0.000201	0.00576	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Mesalazine—Crohn's disease	0.000201	0.00575	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Azathioprine—Crohn's disease	0.0002	0.00572	CcSEcCtD
Fluticasone Propionate—Infestation—Azathioprine—Crohn's disease	0.0002	0.00572	CcSEcCtD
Fluticasone Propionate—Contusion—Prednisone—Crohn's disease	0.000197	0.00565	CcSEcCtD
Fluticasone Propionate—Bronchitis—Mesalazine—Crohn's disease	0.000196	0.00562	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Mesalazine—Crohn's disease	0.000196	0.00561	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000195	0.00558	CcSEcCtD
Fluticasone Propionate—Viral infection—Prednisone—Crohn's disease	0.000191	0.00546	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00019	0.00544	CcSEcCtD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—SMAD3—Crohn's disease	0.000187	0.0138	CbGpPWpGaD
Fluticasone Propionate—Pneumonia—Mesalazine—Crohn's disease	0.000183	0.00524	CcSEcCtD
Fluticasone Propionate—Infestation—Mesalazine—Crohn's disease	0.000182	0.00521	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Mesalazine—Crohn's disease	0.000182	0.00521	CcSEcCtD
Fluticasone Propionate—Cataract—Prednisone—Crohn's disease	0.000181	0.00518	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Mesalazine—Crohn's disease	0.000177	0.00507	CcSEcCtD
Fluticasone Propionate—Epistaxis—Mesalazine—Crohn's disease	0.000172	0.00492	CcSEcCtD
Fluticasone Propionate—Sinusitis—Mesalazine—Crohn's disease	0.000171	0.00489	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Mercaptopurine—Crohn's disease	0.000169	0.00484	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.000167	0.0123	CbGpPWpGaD
Fluticasone Propionate—Pharyngitis—Mesalazine—Crohn's disease	0.000162	0.00465	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Azathioprine—Crohn's disease	0.000162	0.00464	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Azathioprine—Crohn's disease	0.000162	0.00463	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Mesalazine—Crohn's disease	0.000161	0.0046	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Azathioprine—Crohn's disease	0.00016	0.00459	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000158	0.00451	CcSEcCtD
Fluticasone Propionate—Eye disorder—Mesalazine—Crohn's disease	0.000153	0.00437	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Mesalazine—Crohn's disease	0.000152	0.00434	CcSEcCtD
Fluticasone Propionate—Hyperkinesia—Prednisone—Crohn's disease	0.00015	0.0043	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Mesalazine—Crohn's disease	0.000148	0.00423	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Mesalazine—Crohn's disease	0.000147	0.00422	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mercaptopurine—Crohn's disease	0.000146	0.00419	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Azathioprine—Crohn's disease	0.000145	0.00415	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Prednisone—Crohn's disease	0.000144	0.00412	CcSEcCtD
Fluticasone Propionate—Mental disorder—Mesalazine—Crohn's disease	0.000143	0.0041	CcSEcCtD
Fluticasone Propionate—Erythema—Mesalazine—Crohn's disease	0.000142	0.00407	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—MTMR3—Crohn's disease	0.000142	0.0105	CbGpPWpGaD
Fluticasone Propionate—Malaise—Azathioprine—Crohn's disease	0.000141	0.00403	CcSEcCtD
Fluticasone Propionate—PGR—Cellular roles of Anthrax toxin—IL1B—Crohn's disease	0.000138	0.0102	CbGpPWpGaD
Fluticasone Propionate—Muscle spasms—Mesalazine—Crohn's disease	0.000137	0.00392	CcSEcCtD
Fluticasone Propionate—Vomiting—Mercaptopurine—Crohn's disease	0.000136	0.0039	CcSEcCtD
Fluticasone Propionate—Rash—Mercaptopurine—Crohn's disease	0.000135	0.00386	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mercaptopurine—Crohn's disease	0.000135	0.00386	CcSEcCtD
Fluticasone Propionate—Vision blurred—Mesalazine—Crohn's disease	0.000134	0.00384	CcSEcCtD
Fluticasone Propionate—Tremor—Mesalazine—Crohn's disease	0.000133	0.00382	CcSEcCtD
Fluticasone Propionate—Arthralgia—Azathioprine—Crohn's disease	0.000133	0.00381	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000132	0.00378	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Mesalazine—Crohn's disease	0.000132	0.00378	CcSEcCtD
Fluticasone Propionate—Discomfort—Azathioprine—Crohn's disease	0.000131	0.00376	CcSEcCtD
Fluticasone Propionate—Angioedema—Mesalazine—Crohn's disease	0.00013	0.00372	CcSEcCtD
Fluticasone Propionate—Malaise—Mesalazine—Crohn's disease	0.000128	0.00367	CcSEcCtD
Fluticasone Propionate—Nausea—Mercaptopurine—Crohn's disease	0.000127	0.00364	CcSEcCtD
Fluticasone Propionate—Infection—Azathioprine—Crohn's disease	0.000127	0.00363	CcSEcCtD
Fluticasone Propionate—Palpitations—Mesalazine—Crohn's disease	0.000126	0.0036	CcSEcCtD
Fluticasone Propionate—Cough—Mesalazine—Crohn's disease	0.000124	0.00356	CcSEcCtD
Fluticasone Propionate—Skin disorder—Azathioprine—Crohn's disease	0.000124	0.00355	CcSEcCtD
Fluticasone Propionate—Hypertension—Mesalazine—Crohn's disease	0.000123	0.00352	CcSEcCtD
Fluticasone Propionate—Arthralgia—Mesalazine—Crohn's disease	0.000121	0.00347	CcSEcCtD
Fluticasone Propionate—Chest pain—Mesalazine—Crohn's disease	0.000121	0.00347	CcSEcCtD
Fluticasone Propionate—Anxiety—Mesalazine—Crohn's disease	0.000121	0.00346	CcSEcCtD
Fluticasone Propionate—Face oedema—Prednisone—Crohn's disease	0.000121	0.00346	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00012	0.00345	CcSEcCtD
Fluticasone Propionate—Discomfort—Mesalazine—Crohn's disease	0.00012	0.00343	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00012	0.00884	CbGpPWpGaD
Fluticasone Propionate—Irritability—Prednisone—Crohn's disease	0.000119	0.00342	CcSEcCtD
Fluticasone Propionate—Dry mouth—Mesalazine—Crohn's disease	0.000118	0.00339	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000116	0.00333	CcSEcCtD
Fluticasone Propionate—Oedema—Mesalazine—Crohn's disease	0.000116	0.00333	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Mesalazine—Crohn's disease	0.000116	0.00333	CcSEcCtD
Fluticasone Propionate—Infection—Mesalazine—Crohn's disease	0.000115	0.0033	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Mesalazine—Crohn's disease	0.000114	0.00326	CcSEcCtD
Fluticasone Propionate—Tachycardia—Mesalazine—Crohn's disease	0.000113	0.00325	CcSEcCtD
Fluticasone Propionate—Skin disorder—Mesalazine—Crohn's disease	0.000113	0.00323	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Prednisone—Crohn's disease	0.000109	0.00311	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.000107	0.00791	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000106	0.00303	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Azathioprine—Crohn's disease	0.000105	0.00301	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000104	0.00299	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Mesalazine—Crohn's disease	0.000104	0.00296	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Azathioprine—Crohn's disease	0.000101	0.00289	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Azathioprine—Crohn's disease	0.000101	0.00289	CcSEcCtD
Fluticasone Propionate—PGR—Cellular roles of Anthrax toxin—TNF—Crohn's disease	9.99e-05	0.00738	CbGpPWpGaD
Fluticasone Propionate—PGR—Nuclear signaling by ERBB4—JAK2—Crohn's disease	9.95e-05	0.00735	CbGpPWpGaD
Fluticasone Propionate—Pain—Mesalazine—Crohn's disease	9.93e-05	0.00284	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Prednisone—Crohn's disease	9.74e-05	0.00279	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Mesalazine—Crohn's disease	9.57e-05	0.00274	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Mesalazine—Crohn's disease	9.49e-05	0.00272	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	9.43e-05	0.00697	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Azathioprine—Crohn's disease	9.39e-05	0.00269	CcSEcCtD
Fluticasone Propionate—Urticaria—Mesalazine—Crohn's disease	9.22e-05	0.00264	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Mesalazine—Crohn's disease	9.18e-05	0.00263	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Mesalazine—Crohn's disease	9.18e-05	0.00263	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Azathioprine—Crohn's disease	8.72e-05	0.0025	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—RBX1—Crohn's disease	8.58e-05	0.00634	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—SMAD3—Crohn's disease	8.57e-05	0.00634	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Mesalazine—Crohn's disease	8.55e-05	0.00245	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Prednisone—Crohn's disease	8.5e-05	0.00243	CcSEcCtD
Fluticasone Propionate—Dizziness—Azathioprine—Crohn's disease	8.43e-05	0.00241	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—Crohn's disease	8.34e-05	0.00616	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PTPN2—Crohn's disease	8.29e-05	0.00613	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Mesalazine—Crohn's disease	8.21e-05	0.00235	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—PTRF—Crohn's disease	8.16e-05	0.00603	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Azathioprine—Crohn's disease	8.1e-05	0.00232	CcSEcCtD
Fluticasone Propionate—Eye disorder—Prednisone—Crohn's disease	8.08e-05	0.00231	CcSEcCtD
Fluticasone Propionate—Rash—Azathioprine—Crohn's disease	8.04e-05	0.0023	CcSEcCtD
Fluticasone Propionate—Dermatitis—Azathioprine—Crohn's disease	8.03e-05	0.0023	CcSEcCtD
Fluticasone Propionate—Headache—Azathioprine—Crohn's disease	7.98e-05	0.00229	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mesalazine—Crohn's disease	7.94e-05	0.00228	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Prednisone—Crohn's disease	7.81e-05	0.00224	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Prednisone—Crohn's disease	7.72e-05	0.00221	CcSEcCtD
Fluticasone Propionate—Dizziness—Mesalazine—Crohn's disease	7.68e-05	0.0022	CcSEcCtD
Fluticasone Propionate—Mental disorder—Prednisone—Crohn's disease	7.57e-05	0.00217	CcSEcCtD
Fluticasone Propionate—Nausea—Azathioprine—Crohn's disease	7.57e-05	0.00217	CcSEcCtD
Fluticasone Propionate—Malnutrition—Prednisone—Crohn's disease	7.53e-05	0.00216	CcSEcCtD
Fluticasone Propionate—Erythema—Prednisone—Crohn's disease	7.53e-05	0.00216	CcSEcCtD
Fluticasone Propionate—Vomiting—Mesalazine—Crohn's disease	7.38e-05	0.00211	CcSEcCtD
Fluticasone Propionate—Rash—Mesalazine—Crohn's disease	7.32e-05	0.0021	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mesalazine—Crohn's disease	7.31e-05	0.00209	CcSEcCtD
Fluticasone Propionate—Headache—Mesalazine—Crohn's disease	7.27e-05	0.00208	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—F5—Crohn's disease	7.19e-05	0.00531	CbGpPWpGaD
Fluticasone Propionate—Vision blurred—Prednisone—Crohn's disease	7.09e-05	0.00203	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Prednisone—Crohn's disease	6.98e-05	0.002	CcSEcCtD
Fluticasone Propionate—Agitation—Prednisone—Crohn's disease	6.92e-05	0.00198	CcSEcCtD
Fluticasone Propionate—Nausea—Mesalazine—Crohn's disease	6.9e-05	0.00198	CcSEcCtD
Fluticasone Propionate—Angioedema—Prednisone—Crohn's disease	6.88e-05	0.00197	CcSEcCtD
Fluticasone Propionate—Malaise—Prednisone—Crohn's disease	6.79e-05	0.00194	CcSEcCtD
Fluticasone Propionate—Hypertension—Prednisone—Crohn's disease	6.5e-05	0.00186	CcSEcCtD
Fluticasone Propionate—Arthralgia—Prednisone—Crohn's disease	6.41e-05	0.00184	CcSEcCtD
Fluticasone Propionate—Anxiety—Prednisone—Crohn's disease	6.39e-05	0.00183	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	6.36e-05	0.00182	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisone—Crohn's disease	6.33e-05	0.00181	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.27e-05	0.00463	CbGpPWpGaD
Fluticasone Propionate—Oedema—Prednisone—Crohn's disease	6.14e-05	0.00176	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisone—Crohn's disease	6.14e-05	0.00176	CcSEcCtD
Fluticasone Propionate—Infection—Prednisone—Crohn's disease	6.1e-05	0.00175	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Prednisone—Crohn's disease	6.02e-05	0.00173	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL10—Crohn's disease	6.01e-05	0.00444	CbGpPWpGaD
Fluticasone Propionate—Tachycardia—Prednisone—Crohn's disease	6e-05	0.00172	CcSEcCtD
Fluticasone Propionate—Skin disorder—Prednisone—Crohn's disease	5.97e-05	0.00171	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—STAT3—Crohn's disease	5.96e-05	0.00441	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	5.96e-05	0.00441	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—SMAD3—Crohn's disease	5.92e-05	0.00438	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	5.77e-05	0.00427	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	5.62e-05	0.00415	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Prednisone—Crohn's disease	5.6e-05	0.0016	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Endothelins—JAK2—Crohn's disease	5.54e-05	0.00409	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.37e-05	0.00397	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	5.35e-05	0.00395	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—JAK2—Crohn's disease	5.33e-05	0.00394	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	5.15e-05	0.00381	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—UBE2D1—Crohn's disease	5.11e-05	0.00378	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Prednisone—Crohn's disease	5.06e-05	0.00145	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Prednisone—Crohn's disease	5.02e-05	0.00144	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—PTRF—Crohn's disease	4.97e-05	0.00367	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—ZFP36L1—Crohn's disease	4.89e-05	0.00361	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Prednisone—Crohn's disease	4.88e-05	0.0014	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Prednisone—Crohn's disease	4.86e-05	0.00139	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Prednisone—Crohn's disease	4.86e-05	0.00139	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.84e-05	0.00358	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	4.66e-05	0.00344	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.57e-05	0.00338	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Prednisone—Crohn's disease	4.53e-05	0.0013	CcSEcCtD
Fluticasone Propionate—Pruritus—Prednisone—Crohn's disease	4.35e-05	0.00124	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	4.31e-05	0.00319	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IL3—Crohn's disease	4.31e-05	0.00318	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Prednisone—Crohn's disease	4.2e-05	0.0012	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	4.17e-05	0.00308	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—DNMT3A—Crohn's disease	4.16e-05	0.00307	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—Crohn's disease	4.09e-05	0.00303	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—SOCS1—Crohn's disease	4.08e-05	0.00302	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Prednisone—Crohn's disease	4.06e-05	0.00116	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—STAT3—Crohn's disease	3.92e-05	0.00289	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Prednisone—Crohn's disease	3.91e-05	0.00112	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ACKR2—Crohn's disease	3.9e-05	0.00289	CbGpPWpGaD
Fluticasone Propionate—Rash—Prednisone—Crohn's disease	3.87e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisone—Crohn's disease	3.87e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Headache—Prednisone—Crohn's disease	3.85e-05	0.0011	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—F5—Crohn's disease	3.7e-05	0.00274	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MLN—Crohn's disease	3.7e-05	0.00274	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—SMAD3—Crohn's disease	3.66e-05	0.0027	CbGpPWpGaD
Fluticasone Propionate—Nausea—Prednisone—Crohn's disease	3.65e-05	0.00105	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.56e-05	0.00263	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IFNG—Crohn's disease	3.53e-05	0.00261	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—SMAD3—Crohn's disease	3.53e-05	0.00261	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—TYK2—Crohn's disease	3.51e-05	0.0026	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—JAK2—Crohn's disease	3.35e-05	0.00248	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.33e-05	0.00246	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CXCL8—Crohn's disease	3.29e-05	0.00243	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—JAK2—Crohn's disease	3.2e-05	0.00237	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL10—Crohn's disease	3.17e-05	0.00234	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—Crohn's disease	3.11e-05	0.0023	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—UBE2D1—Crohn's disease	3.11e-05	0.0023	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	3.02e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ZFP36L1—Crohn's disease	2.98e-05	0.0022	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Crohn's disease	2.9e-05	0.00214	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PTRF—Crohn's disease	2.87e-05	0.00212	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ACKR2—Crohn's disease	2.82e-05	0.00209	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—HSPA1B—Crohn's disease	2.81e-05	0.00207	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MLN—Crohn's disease	2.68e-05	0.00198	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCR9—Crohn's disease	2.57e-05	0.0019	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—DNMT3A—Crohn's disease	2.53e-05	0.00187	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—UBE2D1—Crohn's disease	2.46e-05	0.00182	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TAGAP—Crohn's disease	2.45e-05	0.00181	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PLA2G4F—Crohn's disease	2.39e-05	0.00177	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GPR65—Crohn's disease	2.39e-05	0.00176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—STAT3—Crohn's disease	2.35e-05	0.00174	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ACKR2—Crohn's disease	2.31e-05	0.00171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ITGA4—Crohn's disease	2.28e-05	0.00168	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—SMAD3—Crohn's disease	2.23e-05	0.00165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL3—Crohn's disease	2.22e-05	0.00164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MLN—Crohn's disease	2.19e-05	0.00162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	2.18e-05	0.00161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—RASGRP1—Crohn's disease	2.15e-05	0.00159	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.15e-05	0.00159	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RSPO3—Crohn's disease	2.14e-05	0.00158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTMR3—Crohn's disease	2.03e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SEL1L—Crohn's disease	2.03e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	2.03e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	2e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TAGAP—Crohn's disease	2e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCR9—Crohn's disease	1.86e-05	0.00137	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—IL6—Crohn's disease	1.85e-05	0.00136	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—UBE2D1—Crohn's disease	1.8e-05	0.00133	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SMAD3—Crohn's disease	1.76e-05	0.0013	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RSPO3—Crohn's disease	1.75e-05	0.00129	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	1.73e-05	0.00128	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GPR65—Crohn's disease	1.72e-05	0.00127	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ZFP36L1—Crohn's disease	1.72e-05	0.00127	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—IL6—Crohn's disease	1.72e-05	0.00127	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—HSPA1B—Crohn's disease	1.71e-05	0.00126	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCR6—Crohn's disease	1.7e-05	0.00126	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	1.67e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	1.66e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SEL1L—Crohn's disease	1.66e-05	0.00122	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	1.63e-05	0.0012	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—STAT3—Crohn's disease	1.61e-05	0.00119	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—FADS1—Crohn's disease	1.58e-05	0.00117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2RA—Crohn's disease	1.56e-05	0.00115	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR9—Crohn's disease	1.52e-05	0.00112	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—UBE2D1—Crohn's disease	1.5e-05	0.00111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTGER4—Crohn's disease	1.5e-05	0.00111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GPX4—Crohn's disease	1.48e-05	0.0011	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—DNMT3A—Crohn's disease	1.46e-05	0.00108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.45e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GCKR—Crohn's disease	1.43e-05	0.00106	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTMR3—Crohn's disease	1.42e-05	0.00105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GPR65—Crohn's disease	1.41e-05	0.00104	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TNF—Crohn's disease	1.39e-05	0.00103	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SMAD3—Crohn's disease	1.29e-05	0.000952	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL3—Crohn's disease	1.27e-05	0.000942	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—RASGRP1—Crohn's disease	1.23e-05	0.000911	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCR6—Crohn's disease	1.23e-05	0.000908	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.2e-05	0.000891	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	1.2e-05	0.000891	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IL6—Crohn's disease	1.13e-05	0.000832	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ALB—Crohn's disease	1.12e-05	0.000831	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RBX1—Crohn's disease	1.11e-05	0.000822	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—FADS1—Crohn's disease	1.1e-05	0.000816	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTGER4—Crohn's disease	1.08e-05	0.0008	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SMAD3—Crohn's disease	1.07e-05	0.000793	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—JAK2—Crohn's disease	1.05e-05	0.000773	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPX4—Crohn's disease	1.03e-05	0.000764	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTMR3—Crohn's disease	1.02e-05	0.000757	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.02e-05	0.000757	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR6—Crohn's disease	1e-05	0.000742	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GCKR—Crohn's disease	9.99e-06	0.000738	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HSPA1B—Crohn's disease	9.88e-06	0.00073	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—UBE2D1—Crohn's disease	9.75e-06	0.00072	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—Crohn's disease	9.72e-06	0.000719	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RIPK2—Crohn's disease	9.45e-06	0.000699	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL3—Crohn's disease	9.22e-06	0.000681	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RBX1—Crohn's disease	9.08e-06	0.000671	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.96e-06	0.000662	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2RA—Crohn's disease	8.93e-06	0.00066	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RASGRP1—Crohn's disease	8.91e-06	0.000659	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTGER4—Crohn's disease	8.84e-06	0.000653	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—UBE2D1—Crohn's disease	8.66e-06	0.00064	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SOCS1—Crohn's disease	8.08e-06	0.000597	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—FADS1—Crohn's disease	7.98e-06	0.00059	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—UBE2D1—Crohn's disease	7.96e-06	0.000589	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RIPK2—Crohn's disease	7.72e-06	0.000571	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL3—Crohn's disease	7.53e-06	0.000557	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPX4—Crohn's disease	7.47e-06	0.000552	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RASGRP1—Crohn's disease	7.28e-06	0.000538	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GCKR—Crohn's disease	7.22e-06	0.000534	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SMAD3—Crohn's disease	6.97e-06	0.000515	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SOCS1—Crohn's disease	6.6e-06	0.000488	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2RA—Crohn's disease	6.46e-06	0.000477	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—TYK2—Crohn's disease	6.29e-06	0.000465	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SMAD3—Crohn's disease	6.2e-06	0.000458	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—JAK2—Crohn's disease	6e-06	0.000444	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SMAD3—Crohn's disease	5.7e-06	0.000421	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.6e-06	0.000414	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—Crohn's disease	5.48e-06	0.000405	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2RA—Crohn's disease	5.27e-06	0.00039	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.76e-06	0.000352	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—Crohn's disease	4.56e-06	0.000337	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TYK2—Crohn's disease	4.55e-06	0.000336	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JAK2—Crohn's disease	4.34e-06	0.000321	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—Crohn's disease	3.99e-06	0.000295	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—Crohn's disease	3.96e-06	0.000293	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TYK2—Crohn's disease	3.72e-06	0.000275	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FADS1—Crohn's disease	3.71e-06	0.000274	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAK2—Crohn's disease	3.54e-06	0.000262	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX4—Crohn's disease	3.47e-06	0.000257	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCKR—Crohn's disease	3.36e-06	0.000248	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—Crohn's disease	3.24e-06	0.000239	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—Crohn's disease	3.18e-06	0.000235	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—Crohn's disease	3.18e-06	0.000235	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—Crohn's disease	3.08e-06	0.000227	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—Crohn's disease	2.78e-06	0.000206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—Crohn's disease	2.6e-06	0.000192	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—Crohn's disease	2.3e-06	0.00017	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—Crohn's disease	2.22e-06	0.000164	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.01e-06	0.000149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—Crohn's disease	1.82e-06	0.000134	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—Crohn's disease	1.07e-06	7.89e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—Crohn's disease	9.34e-07	6.91e-05	CbGpPWpGaD
